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Background: The number of people receiving antidepressants has increased in the past 3 decades, mainly because of people
staying on them longer. However, in many cases long-term treatment is not evidence based and risks increasing side effects.
Additionally, prompting general practitioners (GPs) to review medication does not improve the rate of appropriate discontinuation.
Therefore, GPs and other health professionals may need help to support patients discontinuing antidepressants in primary care.
Objective: This study aims to develop a digital intervention to support practitioners in helping patients discontinue inappropriate
long-term antidepressants (as part of a wider intervention package including a patient digital intervention and patient telephone
support).
Methods: A prototype digital intervention called Advisor for Health Professionals (ADvisor HP) was planned and developed
using theory, evidence, and a person-based approach. The following elements informed development: a literature review and
qualitative synthesis, an in-depth qualitative study, the development of guiding principles for design elements, and theoretical
behavioral analyses. The intervention was then optimized through think-aloud qualitative interviews with health professionals
while they were using the prototype intervention.
Results: Think-aloud qualitative interviews with 19 health professionals suggested that the digital intervention contained useful
information and was readily accessible to practitioners. The development work highlighted a need for further guidance on drug
tapering schedules for practitioners and clarity about who is responsible for broaching the subject of discontinuation. Practitioners
highlighted the need to have information in easily and quickly accessible formats because of time constraints in day-to-day
practice. Some GPs felt that some information was already known to them but understood why this was included. Practitioners
differed in their ideas about how they would use ADvisor HP in practice, with some preferring to read the resource in its entirety
and others wanting to dip in and out as needed. Changes were made to the wording and structure of the intervention in response
to the feedback provided.
Conclusions: ADvisor HP is a digital intervention that has been developed using theory, evidence, and a person-based approach.
The optimization work suggests that practitioners may find this tool to be useful in supporting the reduction of long-term
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antidepressant use. Further quantitative and qualitative evaluation through a randomized controlled trial is needed to examine the
feasibility, effectiveness, and cost-effectiveness of the intervention.
(J Med Internet Res 2021;23(7):e25537) doi: 10.2196/25537
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Introduction
Background
Antidepressant prescribing has increased in England every year
for more than 30 years [1], and Public Health England estimated
that 4.5 million people (around 1 in 10 of the adult population)
were taking an antidepressant in March 2018 [2]. This rise is
mainly because of an increase in long-term use
[3,4]—approximately 40% of antidepressant users have been
on them for 2 years or more and 24% for at least 3 years [2].
Although long-term use of antidepressants is considered
necessary in some cases to prevent relapse, surveys suggest that
approximately one-third to a half of patients on long-term
antidepressants have no evidence-based indication for continuing
long-term use [5-7]. Attempts to discontinue antidepressants in
these patients may improve their quality of life by avoiding
adverse effects that tend to increase with longer-term use [8]
and may also help to reduce the costs of prescriptions and
consultations to the National Health Service [9].
Previous research has suggested that patients may continue to
take antidepressants long term because of a lack of general
practitioner’s (GP) review [10]; however, studies on prompting
GPs to review patients on long-term antidepressants have
resulted in only 6% to 8% of patients discontinuing, which did
not significantly differ from usual care [11,12]. The barriers to
stopping antidepressants are multifaceted, and thus, a complex
approach to support withdrawal is needed, involving patients,
primary care practitioners, and additional psychological support.
Qualitative studies on the long-term use of antidepressants have
highlighted a number of barriers to discontinuation, such as the
fear of relapse and beliefs about the necessity of long-term use
[13]. Importantly, these studies have also highlighted the critical
role of the GP-patient relationship and how this can help or
hinder discontinuation. However, there is comparatively less
research exploring the perspectives and experiences of health
professionals (ie, GPs, nurses, pharmacists, and psychological
practitioners) regarding antidepressant discontinuation. In a
recent qualitative study, Bowers et al [14] highlighted key
factors that served as barriers to GPs supporting patients to
discontinue long-term antidepressants. These included
uncertainty about the responsibility of initiating discussions
about discontinuation, with GPs often suggesting it was the
patients’ responsibility to start these conversations. Fear about
destabilizing patients who were well was also a factor, alongside
a perceived lack of information and support for safe
discontinuation. Importantly, it may be possible to intervene to
address such issues, thereby supporting successful
discontinuation, where appropriate.
Objectives
The REDUCE (Reviewing Long Term Antidepressant Use by
Careful Monitoring in Everyday Practice) program aims to
develop and trial safe, feasible, and effective ways to support
antidepressant discontinuation. In this paper, we describe the
methods involved in the development of a digital intervention
aimed at changing the behavior of health professionals involved
in antidepressant discontinuation as part of the REDUCE
program. We then discuss how this method was implemented
and the findings of the development work.
Methods
The Person-Based Approach
The mixed methods approach used to guide the development
of the intervention for health care professionals takes commonly
applied theory and evidence-based methods and integrates the
person-based approach (PBA) [15]. The PBA is a systematic
approach for integrating in-depth qualitative research across
multiple stages of the development process. It involves the
integration of open-ended qualitative interviews, qualitative
meta-syntheses, and think-aloud qualitative optimization
interviews with relevant theory and quantitative evidence base
(Figure 1). Here, we will describe the key elements of this
approach, including how we drew from theory (through
behavioral analysis and logic modeling) and systematic reviews
and conducted primary qualitative research to develop our
intervention.
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Figure 1. Intervention development method. COM-B: Capability, Opportunity, Motivation-Behavior; NPT: Normalization Process Theory; PBA:
person-based approach; PPI: patient and public involvement; REDUCE: Reviewing Long Term Antidepressant Use by Careful Monitoring in Everyday
Practice.
Phase 1: Intervention Planning
Step 1: Systematic Reviewing
A qualitative thematic synthesis of 22 studies was conducted,
as described in detail elsewhere [13]. In this thematic synthesis,
our team identified barriers and facilitators to antidepressant
discontinuation from both patient and health professional
perspectives. Barriers and facilitators from health professionals’
perspectives were then used to inform the guiding principles
(Textbox 1) and content for the intervention.
Textbox 1. Guiding principles for the intervention package: design objectives and key intervention features relevant to each design objective.
To persuade and inform health professionals about the reasons and benefits of discontinuing antidepressants
• Ensure that the material covers patients’ motivations for stopping
• Include evidence that antidepressants can be withdrawn without harm
To provide rapidly accessible information designed to increase self-efficacy for effectively managing discontinuation in patients
• Simple, unobtrusive interface, using bulleted text as far as possible
• Offer a range of strategies for identifying and managing withdrawal effects
• Use of clear, visually mapped tapering schedules
• Acknowledge flexibility in working with patients
To enable health professionals to support a wide range of patients and be used in a manner that best suits the health professionals
• Provide content that will be relevant for patients in a wide variety of contexts
• Enable use in multiple ways (eg, as a linear educational system or as a resource that can be dipped in and out of), as and when the health professional
deems necessary
Step 2: Primary Qualitative Research
We drew from our previously conducted qualitative study with
health professionals regarding antidepressant discontinuation
(refer to the study by Bowers et al [14] for full paper). This
qualitative work comprised 4 focus groups and 3 individual
interviews with 38 health care professionals. The focus groups
and interviews explored views on long-term antidepressant use,
negotiating the decision to discontinue with patients, their role
in supporting patients, and important elements of the proposed
interventions (including content for practitioners). Professionals
included 21 GPs, 4 GP assistants, 7 nurse practitioners (NPs),
and 6 mental health workers or psychological therapists. We
used themes identified in the interviews and focus groups to
inform the content and mode of presentation or delivery of the
intervention.
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Step 3: Development of Guiding Principles
As part of the PBA, guiding principles—a set of key
assumptions followed throughout the process of the intervention
development—were formulated. They included broad design
objectives that inform how the core intervention strategies are
applied and implemented with the aim to increase engagement
[16]. The qualitive work (ie, focus groups, interviews, and
qualitative metasynthesis) informed the formulation of the
guiding principles for the health professional intervention.
Step 4: Behavioral Analysis and Logic Modeling
We drew on implementation and behavioral theory in addition
to our qualitative work and discussions with experts (including
patient representatives, GPs, psychiatrists, psychologists,
sociologists, and health service researchers) to identify key
components of the intervention. We conducted a behavioral
diagnosis using the Behavior Change Wheel (BCW) and the
COM-B Model (capability, opportunity, motivation and
behavior) of behavior change [17,18] to identify key behaviors
that needed to be addressed or targeted in the intervention and
their determinants or context. Our proposed ideas about
intervention content were then mapped theoretically using the
BCW and Normalization Process Theory (NPT) [19]. NPT is
a framework for understanding the key mechanisms that shape
implementation processes. It focuses on the work that
participants do to incorporate components of complex
interventions into their everyday lives [19]. In addition, we used
logic modeling to draft how the intervention may work to
effectively support appropriate discontinuation. Logic models
[20] represent theories of change in a diagrammatic form. They
are a useful tool to highlight assumptions regarding potentially
important mechanisms and are adapted as data become available.
Step 5: Drafting Intervention Content
The intervention’s content was developed using findings from
the qualitative metasynthesis of the literature, primary qualitative
work, behavioral analysis, and logic modeling. Written
intervention content was drafted by a member of the content
development team (HB) using what was learned from the
qualitative work and theoretical modeling. These drafts were
then discussed by the content development team (HB, AG, and
MG) and then the wider team (which included patients, GPs,
sociologists, psychologists, and psychiatrists). Discussions led
to iterations of the content until the team was in agreement. This
process resulted in a prototype intervention that addressed key
barriers and facilitators identified in the primary qualitative
work and metasynthesis and that fit with the guiding principles,
behavioral analysis, and logic model.
The content was transferred into web-based pages in LifeGuide
(a software program for developing web-based interventions
[21]), and further discussions and iterations took place,
modifying the presentation of information, before reaching an
agreement on the prototype to be used in the intervention
optimization phase.
Phase 2: Intervention Optimization
Design
Following the PBA, think-aloud qualitative studies were used
to optimize a digital prototype of an intervention [15]. They are
designed to explore users’ perspectives on the intervention’s
content and its relevance, appropriateness, and understanding
as well as users’ views on functionality, usability, and design
of an intervention. Ethical approval for the study was granted
by the National Health Service South Central Oxford B Research
Ethics Committee. Participants provided informed consent and
were identified only by participant ID.
Participants
Participants were health professionals from primary care
practices in the south of England who responded to a call from
the local National Institute for Health Research (NIHR) clinical
research network Wessex for health practitioners to participate
in a semistructured face-to-face interview. The study team then
contacted interested participants and arranged to meet them at
their home or at their practice.
Procedure
Eligible participants met with researchers (HB, TK, RL, and/or
SW) who invited them to engage with the digital prototype
intervention and say what they were thinking aloud. When
necessary, the interviewer prompted participants (eg, asking
practitioners, “How do you feel about the information on this
page?”). Interviews ranged from 32 to 82 minutes in length and
were audio recorded. The interview schedule is presented in
Multimedia Appendix 1.
Following each interview, comments were discussed among
the study team. Comments were initially discussed based on
notes from the interviews, and further discussions were
conducted based on the analyzed transcriptions. This was done
to modify the intervention in a timely manner. As a result of
these discussions, amendments were made to the intervention
in an iterative fashion; 4 subsequent intervention versions were
shown to the participants following the first prototype.
Participants participated in only 1 interview. Therefore,
participants who were recruited later in the study saw an updated
and amended version of the intervention, different from the
versions seen by participants recruited earlier. This process
allowed the changes that were made as a result of practitioner
feedback to be shown and discussed with practitioners recruited
later in the study. Interviews with practitioners continued until
data saturation was reached, that is, when comments about the
intervention reflected that no further changes were necessary
and there were, therefore, no new codes identified.
Analysis
Interviews were transcribed verbatim and analyzed using 2
analytical methods. The first method comes from the PBA and
is more rapid than thematic analysis, involving the use of coding
tables specifically designed to highlight positive and negative
comments about the intervention. All minor amendments to the
intervention were agreed upon following discussion with the
intervention development team. Issues that were likely to affect
participant engagement or intervention effectiveness were
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discussed with the broader group before making changes. Along
with positive and negative comment tabulation, we also
conducted a thematic analysis of general or overall views about
the intervention using NVivo software (QSR International)
[22,23]. This more in-depth analysis aimed to capture
participants’views of the intervention and ideas about how they
may engage with it. The thematic analysis was central in making
amendments to the intervention. HB independently coded the
transcripts using thematic analysis and discussed an initial
coding frame with a second researcher (AG). The broader team
was included in discussions about labeling and interpretation.
The findings of the in-depth thematic analysis are presented
here.
Results
Phase 1: Intervention Planning and Development
Step 1: Systematic Reviewing
Our qualitative thematic synthesis identified key barriers and
facilitators to discontinuation for both patients and health
professionals (refer to the study by Maund et al [13] for full
details). The following issues were regarded as key to inform
the development of the health professional intervention:
• GPs reported patient dependence on antidepressants and
patients’ difficult life circumstances as barriers to
discontinuing antidepressants.
• Patients perceived their doctor as the navigator of
discontinuation, responsible for recommending or approving
the decision to discontinue, and responsible for initiating
the discussion.
• Patients expected their doctor to support and guide them
through the discontinuation process.
• Both patients and GPs acknowledged that the GP often does
not have the time necessary to best support discontinuation.
The findings from this thematic synthesis informed the guiding
principles, behavioral analysis, and logic model, which formed
the basis for intervention content selection and development.
Step 2: Primary Qualitative Research
Thematic analysis [22] of the focus groups and interviews
resulted in 5 themes exploring barriers and facilitators for health
professionals initiating and discussing discontinuation with
patients (refer to the study by Bowers et al [14] for further
details of the findings). After discussion, the following issues
were determined to be the most relevant and directly informed
intervention development:
• When neither the health professional nor the patient raises
the topic of discontinuation, this may result in a form of
collusion where both parties are assuming that the other
party wants antidepressant treatment to continue.
• Health professionals were concerned about destabilizing
well patients—some felt that continuing antidepressants
was easier and less risky.
• Knowing the patient’s history and past experiences with
depression and antidepressants facilitated discontinuation
discussions, although poor continuity made such
conversations less likely.
• Insufficient information and understanding of antidepressant
discontinuation made them less confident in their ability to
successfully taper patients off antidepressants.
• Conversations about discontinuation are time consuming
and require follow-up appointments, which are often
limited.
These literature syntheses and qualitative interview findings
informed the development of guiding principles, a behavioral
analysis, the logic model, and the intervention content. For
example, understanding that the GP’s time constraints can be
a barrier resulted in a key design objective being to provide
rapidly accessible information designed to increase self-efficacy
for effectively managing discontinuation in patients (Textbox
1). The qualitative findings also directly informed the content
of the intervention. For example, recognizing the collusion that
results in both parties assuming that the other wants treatment
to continue led to an intervention module dedicated to broaching
the subject (Textbox 2).
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Textbox 2. Outline of the intervention content.
Content and Description
• Why reduce
• A rationale for discontinuation highlighting patients’ views on antidepressants and why they would prefer not to take them and covering
evidence on relapse rates for patients discontinuing in primary care
• Broaching the subject
• Guidance on addressing the topic of discontinuation within a consultation and acknowledging time constraints
• When to start tapering
• Information about which patients might be appropriately considered for discontinuation and what time might be most appropriate to initiate
the withdrawal
• Reduction schedules
• Suggested reduction schedules for different medications under different circumstances (eg, depending on drug half-life or patients’ previous
experiences with withdrawal)
• Dealing with withdrawal symptoms
• Information about distinguishing relapse from withdrawal symptoms and how to respond to mild, moderate, and severe withdrawal symptoms
• Dealing with relapse
• Information about how patients are advised to manage their relapse prevention
• Guidance on when it might be advisable to reinstate antidepressants in the face of relapse
• ADvisor for Health Professionals for patients
• A brief overview of the content covered in the patient digital intervention to enable practitioners to recommend information in the web-based
resource for patients to look at home
• Printable pages
• Printable handouts to give to patients (eg, a tapering regime template)
• Resources
• Links to relevant papers and guidelines related to antidepressant discontinuation
Step 3: Guiding Principles for the REDUCE Intervention
Package
These principles included design objectives and design features
(Textbox 1). Our 2 broad design objectives were (1) to build
confidence that discontinuing antidepressant medication is safe
and achievable in the long term and (2) to be an accessible,
motivational resource that supports patients in managing their
withdrawal, which aligns with their preferences. These
objectives were achieved through the development of the patient
digital intervention (which is described elsewhere [24]) and
through the health professional intervention (eg, patients’views
on enabling empathy and GP support informed the section for
GPs to build their confidence that discontinuation is safe). The
design features that support these objectives are presented in
Textbox 1.
Step 4: Behavioral Analysis and Logic Modeling
The behavioral diagnosis for the health professional intervention
can be found in Multimedia Appendix 2 [17,18]. Reducing and
stopping antidepressant medication was our target behavior,
and reflective motivation and psychological capability were
considered the key constructs for changing this behavior. In
terms of increasing the psychological capability of health
professionals, this would involve improving knowledge about
discontinuation and setting expectations around the withdrawal
process to build self-efficacy in discontinuing antidepressants.
To improve reflective motivation for health professionals, the
intervention targeted beliefs about treatment that may act as
barriers to discontinuation (eg, that withdrawal is always
challenging and unachievable).
Content for particular intervention modules was drafted and
mapped against constructs from the BCW and NPT (Multimedia
Appendix 3). For example, in the module dedicated to providing
a rationale for discontinuing antidepressants, the key BCW
construct addressed is reflective motivation, and for NPT, the
key constructs are enrollment and systematization. The logic
model for the intervention is shown in Figure 2. Depicted in the
logic model are the hypothesized relationships between barriers
and facilitators to discontinuation intervention components,
mechanisms, and outcomes.
J Med Internet Res 2021 | vol. 23 | iss. 7 | e25537 | p. 6https://www.jmir.org/2021/7/e25537
(page number not for citation purposes)
Bowers et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 2. Logic model for Advisor HP. AD: antidepressant; GP: general practitioner; HP: health practitioner.
Step 5: Drafting Intervention Content
A prototype digital web-based intervention was developed for
health professionals involved in supporting patients to
discontinue long-term antidepressant use. The contents of the
web-based intervention are described in Textbox 2. A digital
intervention for patients was also developed, as reported
separately [24].
The intervention was designed to be flexible to cater to the time
constraints under which GPs work. As such, the topics covered
were optional and accessible from the main menu page; users
could skip content that they felt would not be beneficial to them.
This also meant that necessary information could be accessed
quickly during a consultation.
Phase 2: Intervention Optimization
Participants
Of the 32 practitioners who expressed interest, 13 could not be
reached by the study team or could not take part (eg, because
of time constraints or sickness), resulting in a final sample of
19 practitioners (2 NPs and 17 GPs); there were 8 men and 11
women. The mean age was 44.29 (SD 7.13) years, and the mean
number of years since qualification was 14.39 (SD 7.77) years
(Table 1).
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Summary of Thematic Analysis
The thematic analysis of the 19 transcripts resulted in the
following five themes: how Advisor for Health Professionals
(ADvisor HP) would be used in practice, pitching at the right
level for health professionals, ADvisor HP is evidence based,
the need for brevity and quick access, and ADvisor HP is useful.
Participant identifiers are presented after each quote, and the
iteration number refers to the iteration of the intervention that
the practitioner saw (ie, iteration 1 means that the participant
saw the first iteration of the intervention). The changes made
at each iteration are listed in Textbox 3.
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Textbox 3. Examples of changes made at each iteration based on the feedback from the think-aloud interview.
Changes made following iteration 1 feedback
• Clarified reporting of statistics on relapse rates after discontinuation
• Clarified that side effects improve once the antidepressant is stopped
• Provided further clarity around antidepressant use and discontinuation for treating anxiety
• Added qualifying statements such as “experienced GPs will know” to address comments around some of the information being well-known to
more experienced general practitioners (GPs) but necessary for newly qualified GPs and nurse practitioners
• Added that there is evidence to support that asking about additional concerns in a consultation does not extend the length of a consultation
• Amended the definition of patients who are currently well to include those who may still have mild symptoms
• Emphasized that the included reduction schedules are suggestions and may be individualized
• Fixed typos
• Added clarity on the timeframe of withdrawal symptoms compared with symptoms of relapse
• Provided specific information about anxiety as a withdrawal symptom
Changes made following iteration 2 feedback
• Revised text to be more concise, using more bullet points
• Changed navigation, so that each module provides an overview with an option to read about it in more detail
• Revised tone to be less prescriptive
Changes made following iteration 3 feedback
• Formatting changes (eg, font choices, text box color, and image layout)
• Navigation changes (eg, making the end of a section and navigation back to the main menu clearer)
• Correction of typos
Changes made following iteration 4 feedback
• Navigation buttons amended (ie, removing “exit” buttons to help people navigate back to the main menu)
• Added clarity around what information patients get from their digital intervention
• Revised wording around the timing of tapering regimes
How ADvisor HP Would Be Used in Practice
Participants described using ADvisor HP as a resource of
information which they can refer to. Nine participants felt that
they would first read through ADvisor HP as a whole and that
once all of the information was read, they would not need to
refer back to the same information many times:
I really like it. Is it potentially going to be — I mean
— not quite a one-off visit...but, you know, if you had
worked all the way through it, yes, you don’t have a
photographic memory, but — because you’ve given
us some nice, simplistic regimes, it isn’t something
necessarily that I’m going to refer to umpteen times
a day [I: Right], because, of course, once you’ve done
it three or four times, you’re going to know what that
regime is. [GP/22/01, iteration 4]
Many health professionals liked that they could engage with
the intervention in different ways, for example, dipping in and
out (n=4) and using in a targeted fashion for specific knowledge,
as needed (n=7). Two participants said they would save a
shortcut on their computer for easy and quick access to
information if and when they needed it:
I do like that you pick what you want to read and so
you can dip in with what you think you want to know
and dip out. It’s your choice what you do; you don’t
have to read through the whole thing to get to what
you’re particularly interested in, because there will
be times when you think — actually I just don’t know
what to do about — about that, so you can dip in and
look at that. So, yes, I like that. [GP/11/02, iteration
1]
Three health professionals (2 nurses and 1 GP) talked about
using ADvisor HP more regularly and making it a part of
everyday practice:
Yes, I would definitely use it in practice — on a
day-to-day — like I said, just looking in between
consultations or if I had a particular patient that I’d
discussed it with and — I may even kind of ring them
back if I’d looked at it after the consultation and make
suggestions. [NP/08/01, iteration 1]
Some health professionals talked about printing copies of the
information both for easy access for themselves and to hand to
patients, as they felt there was something beneficial in the act
of physically giving something. Therefore, we added 2 printouts
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to be given to patients—one to direct patients to specific content
in the patient intervention, ADvisor, and another to be used to
provide a personalized tapering regime:
Patients like to go out the room holding something,
don’t they, whether it’s a prescription or something
and to give them something to do for themselves, gives
them a bit more ownership of it and it feels like
they’re doing something for themselves, rather than
having to rely on us and the tablets all the time.
[GP/18/01, iteration 2]
Very few health professionals felt that they would use ADvisor
HP within a consultation for their own information. However,
some talked about using ADvisor HP collaboratively with a
patient within a consultation as a way of showing the patient
reliable information and providing evidence for their clinical
decision making:
I think sometimes, although it’s for the doctor,
sometimes it’s quite useful to show the patients these
things as well. I don’t tend to use the internet that
much but sometimes when you get a leaflet or you
find something that’s kind of - and to us, if you show
it to the patients as well, then it builds up that trust a
bit more as well, that that’s why you’re doing it. You
show evidence for things. [GP/18/01, iteration 2]
When discussing how they envisage ADvisor HP being used
in practice, 3 GPs reported that they did not feel they would use
it. The reasons they provided were that it would be difficult to
find the time to read it and that they already knew the
information contained in ADvisor HP:
I think most GPs would love to get their patients off
antidepressants; if we could give patients a link to a
website supporting that, then that’s great and we
could come to a plan together, but I don’t know that
I necessarily need to read that, to make that plan.
[GP/16/01, iteration 2]
There was acknowledgment among some health professionals
that work would need to be done to get other HPs to engage
with and be aware of ADvisor HP:
I think it would be really helpful. I’m not quite sure
how you’re going to — market it as such, because
obviously all of us get absolutely inundated with —
there’s a new tool for this and a new resource for that
and new guidance on this and — we have to cherry
pick what we actually even — bother looking at, let
alone going through. [GP/22/01, iteration 4]
Pitching It at the Right Level for GPs
Later iterations reduced the detail of information where health
professionals highlighted that it was common knowledge or
unnecessary and it was stated in ADvisor HP that information
may not be new but may act as a reminder (Textbox 3). Two
GPs also commented that the tone of the intervention could be
less prescriptive:
So in, under this talking to the patient heading, sounds
like a lot of it is so obvious that it’s patronising and
could be annoying to a GP. [GP/15/01, iteration 1]
Some of these health professionals explained that it was still
useful to include information they already knew, as it can act
as a reminder and may be useful to less experienced practitioners
and trainees. A GP explained that it is reassuring to read that
the guidance corresponds to what they are already doing in
practice:
I suppose a lot of it — you know — I feel I know
already, in truth, but there’s — it’s a reminder. And
actually, you know, it’s a prompt that when — when
I’m next speaking to somebody, I might just — and
we’re talking about coming off antidepressants, I
might actually just specifically touch on those areas,
whereas before I would have probably waited until
they told me those things. [GP/27/01, iteration 5]
A GP explained that information that may seem obvious to some
GPs does not need to be excluded from ADvisor HP. By having
a main menu and easy access to different sections, one could
quickly move from one section to another if they felt that the
information was not something they needed to read:
If you go on to a section and you think, I know that
already, you could always come out of it. [GP/11/02,
iteration 1]
Despite these comments, many of the GPs reported learning
something new in ADvisor HP, in particular, new information
about antidepressants (eg, switching to another antidepressant
to help avoid distressing withdrawal), patient perspectives (eg,
patients expect their GP to initiate discontinuation
conversations), and how psychological therapeutic techniques
may help patients to discontinue antidepressants:
That’s interesting. It says many patients may continue
taking their antidepressant because they believe the
GP wants them to, because I’ve always thought it was
almost the opposite way around, that patients want
to carry on their antidepressants and GPs are trying
to take them off it. And I often find that people are
saying — please don’t make me stop them and
wanting to carry on with them for longer, but
probably I’m wrong; maybe that’s just an anecdotal
thing for me and it seems, from this, that they’ve
shown that if a GP doesn’t suggest discontinuing,
that they’ll just carry on and on and on. [GP/27/03,
iteration 5]
Two GPs explicitly stated that they would change their practice
following new information in ADvisor HP. They would now
be more inclined to broach the subject of stopping, more likely
to ask patients about upcoming life events that may interfere
and be less inclined to restart antidepressants in the face of
withdrawal symptoms:
So if that [symptoms of depression or anxiety]
happens within a couple of days of the dose change
then it’s probably not a relapse; it’s probably more
a withdrawal. But it’s a good reminder for me,
because I think if I had a patient come back to me,
having cut their SSRI, then within a few days was
saying they felt awful, I might just be tempted to put
them back on it, really. [I: Right] Whereas actually
J Med Internet Res 2021 | vol. 23 | iss. 7 | e25537 | p. 10https://www.jmir.org/2021/7/e25537
(page number not for citation purposes)
Bowers et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
now I might be tempted to — encourage them to stay
with it for a bit longer. [GP/27/01, iteration 5]
ADvisor HP is Evidence Based
Health professionals reported reassurance that the information
was in line with the National Institute for Health and Care
Excellence (NICE) guidance and liked the references to research
to support the information in ADvisor HP:
So I guess it’s reassuring to have some evidence-base
and some NICE guidelines incorporated. As this is a
practitioner website, I guess it — it’s helpful to give
peace of mind and reassure people that actually it’s
the right thing to do, to come off when — when certain
criteria have been fulfilled, as it were [GP/08/01,
iteration 1]
In particular, evidence showing the relatively low relapse rates
of patients was found to be reassuring by 5 of the GPs in the
sample. They also felt that these figures would be useful in
reassuring the patient, who may fear discontinuation:
I actually — I’m quite impressed with the number
that came off; that’s more than I thought. [I: Okay]
So that’s quite good and it probably would make me
a bit more motivated to try and get people off.
[GP/16/02, iteration 2]
Also, 2 GPs acknowledged that the existing guidelines are not
easy to navigate when looking for particular pieces of
information or guidance. They felt that ADvisor HP made it
easy to access the information needed:
So I think a lot of people would be interested in the
research evidence for it. Yes, just looking who is
eligible to discontinue, which I think is quite
important, because NICE guidelines tend to be a little
bit thick and long winded and it’s hard to really
condense them, I think, to get the information you
need, sometimes, so that’s quite helpful, having just
those several bullets points there. [GP/25/01, iteration
4]
The Need for Brevity
Many health professionals highlighted their strict time
constraints and, thus, the need to access information quickly.
Five GPs commented, particularly in the earlier iterations, that
ADvisor HP was time consuming to go through and that this
may prevent them from being able to use the intervention. A
large number of health professionals reported that there was
more information than necessary. Some suggested that although
the content was useful, it could be presented more concisely:
I think the overwhelming thing is probably we have
such limited time and we need to be able to look at
everything so quickly and you need to be able to find
something straightaway. So I think it is, because you
very much go straight into it [the main menu] and
then you go to Reduction Schedules, as long as you’ve
looked at it before and know where they are.
[GP/21/01, iteration 4]
However, 4 GPs and 1 NP reported that the intervention was
concise and not too big to go through. Nevertheless, in further
iterations of ADvisor HP, the content was revised to be more
concise. It is possible that these changes resulted in health
professionals finding the content more manageable to go
through:
I like the type font, I think it’s quite clear, the photos
are appropriate. It’s very easy to read. The whole
package isn’t too big and you know what you’re
dealing with. [GP/21/02, iteration 5]
ADvisor HP Is Useful
Throughout the interviews, GPs and nurses commented that the
information in ADvisor HP was useful. There were mixed views,
in that different pieces of information were reported as useful
by different participants. This fits with the guiding principles
of ADvisor HP, in that the information should be flexible so
that participants can access what they find useful, without the
need to view the information they may not wish to view at that
time. Tapering regimes were highlighted as particularly useful
by 13 of the 15 health professionals, which fits with our primary
qualitative evidence that there is a lack of existing clear,
accessible guidance:
I think the most helpful bits are probably actually
looking at the advice on the medications and the exact
dosage regimes to use and I think probably the
information for the patients is all quite good.
[GP/21/01, iteration 4]
Two GPs did not find tapering guidance useful, reporting that
they already knew it and that drug regimens need tailoring to
each individual patient.
Many health professionals also reported that the information
on how to deal with withdrawal symptoms and how to
distinguish between them and signs of relapse was useful:
Yes, the contrast between withdrawal and relapse,
especially the timeframe.... Yes, I think that’s quite a
good table; I like that [GP/16/01, iteration 2]
By the end of the interviews, the main issues with ADvisor HP
were resolved. The intervention was deemed ready for the
forthcoming feasibility trial (which will be reported elsewhere).
Discussion
Principal Findings
Using the PBA, we developed a digital intervention designed
to support health care professionals helping patients to withdraw
from long-term antidepressant treatment. This intervention was
based on a systematic literature review, in-depth qualitative
research, and discussion with experts. The intervention aims to
provide easily accessible, evidence-based guidance for health
professionals and is grounded in practitioner perspectives and
preferences. It was designed to be part of an intervention
package along with a patient digital resource and patient
telephone support with a psychological practitioner.
The think-aloud interview findings suggest that ADvisor HP
could work in practice, as the information is quickly accessible
and based on the latest evidence. The intervention will be
examined in a feasibility randomized control trial in which a
J Med Internet Res 2021 | vol. 23 | iss. 7 | e25537 | p. 11https://www.jmir.org/2021/7/e25537
(page number not for citation purposes)
Bowers et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
qualitative and quantitative process evaluation will be carried
out. This feasibility study will explore how practitioners engage
with the intervention to support to patients discontinuing
antidepressants. Further intervention modifications may occur
in response to the findings of the feasibility trial, in line with
the latter stages of the PBA [15].
A digital intervention may be particularly useful in imparting
knowledge and possibly more limited in changing practitioners’
attitudes and developing their skills. Educational research
suggests that attitudes toward mental health problems may need
to be challenged in peer group discussions and that a
combination of modeling, role-play, and video feedback might
be needed for the acquisition of new skills [25]. However, such
educational initiatives are expensive and time consuming, and
given the high prevalence of inappropriate long-term
prescription of antidepressants and the time pressures under
which primary care practitioners work, interventions that can
quickly be applied at scale are needed.
Many previously developed tools to support practitioners in
deprescribing have focused on clinical decision-making support
systems or polypharmacy, particularly in older adult patients
[26,27]. These tools often result in increased deprescribing;
however, our qualitative work suggests that further education
and belief or attitude change around antidepressant
discontinuation would be needed to support deprescribing for
long-term antidepressants. A study of antibiotic prescribing
provided GPs with an internet education tool that was optimized
using think-aloud methods [28]. This intervention resulted in
significantly lower rates of antibiotic prescribing [29]. In using
the PBA to develop ADvisor HP, health professionals’ beliefs
have informed the initial development and the optimization of
the intervention, which may therefore support belief and
behavior change.
Limitations
This study has some limitations. Many of the practitioners
recruited for the focus groups and think-aloud interviews were
recruited from less deprived regions of the south of England.
Many patients who live in these regions are from more affluent
backgrounds, with few from ethnic minorities. Therefore, the
perspectives in this work may not represent broader cultures
and experiences of antidepressant treatment nationally. In the
feasibility work and the subsequent fully powered randomized
control trial, further qualitative work will be carried out with a
larger and more diverse population of practitioners in England
and Wales.
It is possible that the practitioners who were interested in
participating were already interested in mental health research
and may, therefore, be more knowledgeable than other
practitioners who may show a less keen interest in this research
topic. The potential bias in our qualitative sample may explain
why some GPs felt that the information was not new. Some GPs
who participated in the think-aloud interviews felt that they did
not need the information in the intervention, but nevertheless,
they thought that it would be useful for GP trainees and doctors
who are relatively new to UK family practice. Recruiting
practices in different regions with a more diverse sample in the
feasibility and main trials may encourage participating
practitioners who are less informed about antidepressant
discontinuation to take part. This development work included
only 2 NPs, of whom both were prescribers responsible for
managing long-term antidepressant use in primary care. Many
practices do not involve NPs in the management and
discontinuation of antidepressants. This limited representation
of NPs made it difficult to identify differences between GPs’
perspectives and nurses’perspectives. Conducting more research
with NPs and other health care professionals who may be
involved in antidepressant discontinuation would be useful to
further understand how this intervention may be used. Exploring
views on the intervention with a broader sample will help ensure
that the intervention is pitched at the right level.
Conclusions
This development work has demonstrated the need for a brief
and accessible intervention for health professionals. In addition,
the think-aloud interviews suggested that the developed
intervention may contribute to a change in attitudes and
behaviors related to antidepressant discontinuation. The
randomized trial will test whether the intervention works in
terms of enhancing the discontinuation of antidepressants, while
measuring the effects on depressive symptoms.
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